59 results on '"W. Mao"'
Search Results
2. A validation study of a continuous automatic measurement of the mechanical power in ARDS patients
3. EP07.02-005 Multicenter Clinical Analysis, Gene Expression Profiling and Correlation Analysis of Immune Cell Infiltration in Pleural Mesothelioma
4. Comparison of Hematotoxicity of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor (PEG-rhG-CSF) Combined with Dual-Agent Concurrent Chemoradiotherapy and Cisplatin Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
5. Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy
6. 37P Pralsetinib in acquired RET fusion-positive advanced non-small cell lung cancer patients after resistance to EGFR/ALK-TKI: A China multi-center, real-world data (RWD) analysis
7. 53P Baseline PET/CT deep radiomics signature apply for identifying bevacizumab sensitivity of RAS-mutant colorectal cancer liver metastases patients
8. A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump ≥4 cm)
9. FP14.11 Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study
10. Design of a cusped field thruster for drag-free flight
11. TL response of LiF:Mg,Cu,P (GR200A and GR207A) exposed to high-energy 12C ions
12. Synthesis and fabrication of silver nanowires embedded in PVP fibers by near-field electrospinning process
13. OA13.06 Final Report of a Prospective Randomized Study on Thoracic Radiotherapy Target Volumes with Radiation Dosimetric and Pathologic Analyses
14. MA14.05 A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)
15. Adjuvant Intensity-Modulated Radiotherapy with Concurrent Chemotherapy after Radical Surgery for Gastric Cancer at a Municipal Tertiary Comprehensive Hospital in China
16. CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics
17. Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation
18. P2.03-047 The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer
19. A New Era of Prospective Real-World Safety Evaluation
20. Deformation behavior and mechanical properties of polycrystalline and single crystal alumina during nanoindentation
21. Phase III Randomized Study of Preoperative Versus Postoperative Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
22. The Central-Peripheral Trade-off Effects Elicited by Negative Emotional Stimuli in Directed Forgetting: ERP Evidence from the Encoding Phase
23. A serum miRNA biomarker panel for the detection of early stage non-small cell lung cancer
24. TCT-14 ABSORB FIRST: 1-year clinical outcomes from a prospective, multi-center, global, real-world registry
25. Experimental and DFT studies on the DNA-binding trend and spectral properties of complexes [Ru(bpy)2L]2+ (L=dmdpq, dpq, and dcdpq)
26. Improvement in the oxidation resistance of the TiAl-based alloy by liquid-phase siliconizing
27. On the dependence of in-grain subdivision and deformation texture of aluminum on grain interaction
28. JCES 01.10 The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer
29. PUB061 Circulating uPA as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
30. P3.14-004 Pathological Study on the Clinical Target Volume (CTV) in Limited-Stage SCLC for CT-Simulation Based Thoracic Radiotherapy Planning
31. MA 09.01 A Propensity-Matched Analysis of Lobectomy and Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer
32. P3.14-015 A Propensity Matched Analysis of SBRT and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in Patients at High Risk for Lobectomy
33. A Propensity Matched Analysis of Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non–small Cell Lung Cancer in Patients at High Risk for Lobectomy
34. Detects esophageal squamous cell carcinoma via liquid biopsy of circulating exosomes
35. TCT-39 Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study
36. 2236 Survival outcomes in patients with locally advanced esophageal squamouscell carcinoma treated with nab-paclitaxel and cisplatin as neoadjuvant chemotherapy
37. Biocontrol of selected soilborne diseases of tomato and pepper plants
38. A Retrospective Study of Shrinking Field Radiation Therapy During Chemoradiation Therapy in Stage III Non-Small Cell Lung Cancer
39. A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus
40. A Computer System for Skeletal Growth Measurement
41. CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY
42. Inhomogeneity of rolling texture in Fe28Al2Cr alloy
43. A coded block adaptive neural network system with a radical-partitioned structure for large-volume Chinese characters recognition
44. Morphological characterization of surface-induced platelet activation
45. 9035 POSTER A National, Multi Center, Randomized, Open-label, Phase II Study of Erlotinib Versus Gemcitabine (GEM) Plus Cisplatin as Neoadjuvant Treatment in Stage IIIA-N2 Non-small-cell Lung Cancer (NSCLC) Patients (pts) With Activating EGFR Mutations (C-TONG 1103)
46. Treatment of smaller coronary vessels with XIENCE V® everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study
47. A GEOMETRIC QA TOOL FOR SBRT DEDICATED LINACS
48. PRELMINARY CHARACTERIZATION OF A DEDICATED IMAGE-GUIDED SBRT SYSTEM
49. TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study
50. Epidermal Growth Factor Receptor Mutation in Small Cell Lung Cancer Patients Detected by Mutant-Enriched Liquidchip Technology from Plasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.